Clinical Trial Update: Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating gemcitabine with fractionated stereotactic radiotherapy for unresectable pancreatic adenocarcinoma has completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Fractionated stereotactic radiotherapy
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Stanford University | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-15